Assertio Accounts Payable from 2010 to 2024

ASRT Stock  USD 1.01  0.07  7.45%   
Assertio Therapeutics Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount Assertio Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents Assertio Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
1997-09-30
Previous Quarter
15.3 M
Current Value
13.2 M
Quarterly Volatility
23.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Assertio Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Assertio Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 3.2 M, Total Revenue of 128 M or Gross Profit of 112.5 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0 or PTB Ratio of 0.52. Assertio financial statements analysis is a perfect complement when working with Assertio Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Assertio Therapeutics Correlation against competitors.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.

Latest Assertio Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Assertio Therapeutics over the last few years. An accounting item on the balance sheet that represents Assertio Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Assertio Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Assertio Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Assertio Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

Assertio Accounts Payable Regression Statistics

Arithmetic Mean24,792,841
Geometric Mean8,794,998
Coefficient Of Variation198.30
Mean Deviation26,652,576
Median13,439,000
Standard Deviation49,163,327
Sample Variance2417T
Range196.7M
R-Value(0.1)
Mean Square Error2578.1T
R-Squared0.01
Significance0.73
Slope(1,074,420)
Total Sum of Squares33838.5T

Assertio Accounts Payable History

202415.6 M
202313.4 M
2022M
20216.7 M
202014.8 M
201916.2 M
20186.1 M

About Assertio Therapeutics Financial Statements

Assertio Therapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Assertio Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Assertio Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Assertio Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable13.4 M15.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.